残余胆固醇与慢性肾脏病患者心血管病变关系的研究进展

王志刚; 王景福

doi:10.3969/j.issn.1671-4091.2026.05.009

PDF(451 KB)

中国血液净化 ›› 2026, Vol. 25 ›› Issue (05) : 407-410. DOI: 10.3969/j.issn.1671-4091.2026.05.009

综述

残余胆固醇与慢性肾脏病患者心血管病变关系的研究进展

王志刚王景福

作者信息 +

Research progress in the relationship between remnant cholesterol and cardiovascular disease in patients with chronic kidney disease

WANG Zhi-gang, WANG Jing-fu

Author information +

文章历史 +

摘要

残余胆固醇(remnant cholesterol,RC)是富含三酰甘油的脂蛋白胆固醇，以禁食状态下的中间密度脂蛋白(intermediate density lipoprotein,IDL)和极低密度脂蛋白(very low density lipoprotein,vLDL)及非禁食状态的乳糜微粒残余物为存在形式。目前RC主要通过计算获取，即RC=总胆固醇(total cholesterol，TC)-高密度脂蛋白胆固醇(high-density lipoprotein cholesterol，HDL-C)-低密度脂蛋白胆固醇(low-density lipoprotein cholesterol，LDL-C)。RC是心血管病变的重要危险因素，心血管并发症是慢性肾脏病(chronic kidney disease，CKD)患者首位死亡原因。本文就CKD患者在不同疾病状态下的血脂特点及RC水平与心血管并发症的关系进行综述，以期为慢性肾脏病患者心血管并发症的早期识别、精准干预提供新思路。

Abstract

Remnant cholesterol (RC) is the cholesterol component of triglyceride-rich lipoproteins, existing in the form of intermediate-density lipoprotein (IDL) and very low-density lipoprotein (vLDL) in the fasting state, and as chylomicron remnants in the non-fasting state. Currently, the primary method to obtain RC content is through the calculation of RC=total cholesterol (TC) - high-density lipoprotein cholesterol (HDL-C) - low-density lipoprotein cholesterol (LDL-C). RC is a significant risk factor for cardiovascular diseases, while cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD). This article reviews the characteristics of blood lipids and the relationship between RC level and cardiovascular complications in CKD patients under various disease conditions, aiming to provide new insights into early identification and precise intervention of cardiovascular complications in CKD patients.

导出引用

王志刚王景福. 残余胆固醇与慢性肾脏病患者心血管病变关系的研究进展[J]. 中国血液净化. 2026, 25(05): 407-410 https://doi.org/10.3969/j.issn.1671-4091.2026.05.009

WANG Zhi-gang, WANG Jing-fu. Research progress in the relationship between remnant cholesterol and cardiovascular disease in patients with chronic kidney disease[J]. Chinese Journal of Blood Purification. 2026, 25(05): 407-410 https://doi.org/10.3969/j.issn.1671-4091.2026.05.009

中图分类号： R692

参考文献

[1]VARBO A, BENN M, TYBJ?RG-HANSEN A, et al.Remnant cholesterol as a causal risk factor for ischemic heart disease[J].Journal of the American College of Cardiology, 2013, 61(4):427-436
[2]VARBO A, NORDESTGAARD B G.Remnant lipoproteins[J].Current Opinion in Lipidology, 2017, 28(4):300-307
[3]STüRZEBECHER P E, KATZMANN J L, LAUFS U.What is 'remnant cholesterol'?[J].European Heart Journal, 2023, 44(16):1446-1448
[4]JEPSEN A M, LANGSTED A, VARBO A, et al.Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease[J].Clinical Chemistry, 2016, 62(4):593-604
[5]BORéN J, TASKINEN M R, BJ?RNSON E, et al.Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia[J].Nature Reviews Cardiology, 2022, 19(9):577-592
[6]ROSENSON R S, SHOTT S, LU L, et al.Hypertriglyceridemia and other factors associated with plasma viscosity[J].The American Journal of Medicine, 2001, 110(6):488-492
[7] RAJA V, AGUIAR C, ALSAYED N, et al.Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook[J].Atherosclerosis, 2023, 383(8):117-312
[8]NORATA G D, GRIGORE L, RASELLI S, et al.Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: Molecular mechanisms and gene expression studies[J].Journal of Molecular and Cellular Cardiology, 2006, 40(4):484-494
[9]LI B, ZHOU X, LIU Y, et al.Remnant Cholesterol is More Strongly Associated with Arterial Stiffness than Traditional Lipids and Lipid Ratios in the General Chinese Population[J].Journal of Atherosclerosis and Thrombosis, 2024, 31(5):587-602
[10]XU X, WANG Z, HUANG R, et al.Remnant Cholesterol in Young Adulthood Is Associated With Left Ventricular Remodeling and Dysfunction in Middle Age: The CARDIA Study[J].Circulation: Cardiovascular Imaging, 2023, 16(11):e015589-
[11]WADSTR?M B N, BAHRAIMI H S Z.Remnant Cholesterol-A Novel Risk Marker for Left Ventricular Remodeling and Dysfunction[J].Circulation: Cardiovascular Imaging, 2023, 16(11):e016110-
[12] LIU J, FAN F, LIU B, et al.Association between remnant cholesterol and arterial stiffness in a Chinese community-based population: A cross-sectional study[J].Frontiers in Cardiovascular Medicine,, 2022, 9:993097-
[13]CHIRINOS J A, SEGERS P, HUGHES T, et al.Large-Artery Stiffness in Health and Disease: JACC State-of-the-Art Review[J].Journal of the American College of Cardiology, 2019, 74(9):1237-1263
[14]YAMAMOTO H, MATSUI T.Molecular Mechanisms of Macroautophagy,Microautophagy,and Chaperone-Mediated Autophagy[J].Journal of Nippon Medical School, 2024, 91(1):2-9
[15]SONG Y F, LIU J J, ZHAO K, et al.Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases[JOL][J].Cell Metabolism, 2021, 33(10):1917-1918
[16]MANDAVIA C H, PULAKAT L, DEMARCO V, et al.Over-nutrition and metabolic cardiomyopathy[J].Metabolism, 2012, 61(9):1205-1210
[17]DA SILVA R M S, DE MELLO R J V.Fat deposition in the left ventricle: descriptive and observacional study in autopsy[J].Lipids in Health and Disease, 2017, 16(1):86-86
[18]ELíAS-LóPEZ D, VEDEL-KROGH S, KOBYLECKI C J, et al.Impaired Renal Function With Higher Remnant Cholesterol Related to Risk of Atherosclerotic Cardiovascular Disease: A Cohort Study[J].Arteriosclerosis, Thrombosis, and Vascular Biology, 2024, 44(12):2647-2658
[19]MEI X, WANG Y, SUN R, et al.Association of remnant cholesterol with coronary heart disease and severity of coronary artery stenosis in non-dialysis patients with stage 3-5 chronic kidney disease[J].Nutrition, Metabolism and Cardiovascular Diseases, 2025, 35(5):103852-
[20]KOBAYASHI Y, FUJIWARA T, HARUNA A, et al.Omega-3 Fatty Acids Reduce Remnant-like Lipoprotein Cholesterol and Improve the Ankle-Brachial Index of Hemodialysis Patients with Dyslipidemia: A Pilot Study[J].Medicina, 2023, 60(1):75-
[21] 杜柯锐.维持性血液透析患者基线残余胆固醇水平对生存的影响[D]. 延安大学, 2023.
[22]GUO J, PENG Y, LIU R, et al.Remnant cholesterol predicts cardiovascular mortality beyond low-density lipoprotein cholesterol in patients with peritoneal dialysis[J].Journal of Clinical Lipidology, 2023, 17(6):708-716
[23]DENG J, TANG R, CHEN J, et al.Remnant cholesterol as a risk factor for all-cause and cardiovascular mortality in incident peritoneal dialysis patients[J].Nutrition, Metabolism and Cardiovascular Diseases, 2023, 33(5):1049-1056
[24]KEANE W F, TOMASSINI J E, NEFF D R.Lipid abnormalities in patients with chronic kidney disease: Implications for the pathophysiology of atherosclerosis[J].Journal of Atherosclerosis and Thrombosis, 2013, 20(2):123-133
[25]CHAN M K, PERSAUD J, VARGHESE Z, et al.Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients[J].Kidney International, 1984, 25(5):812-818
[26]WEINTRAUB M S, EISENBERG S, BRESLOW J L.Different patterns of postprandial lipoprotein metabolism in normal,type IIa,type IIb,and type IV hyperlipoproteinemic individuals: Effects of treatment with cholestyramine and gemfibrozil[J].Journal of Clinical Investigation, 1987, 79(4):1110-1119
[27]GALLIENI M, MUSETTI C, GRANATA A, et al.Metabolic consequences of peritoneal dialysis treatment[J].Panminerva Medica, 2009, 51(3):175-185
[28]Cholesterol Treatment Trialists' CTT Collaboration, HERRINGTON W G, EMBERSON J, et al.Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials[J].The Lancet Diabetes & Endocrinology, 2016, 4(10):829-839